Eledon Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.5M, a 40.1% decline year-over-year.
  • Eledon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$46.9M, a 48.3% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$43M, a 51.4% increase from 2022.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$88.4M, a 140% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$36.9M, a 99.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43M +$45.4M +51.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$88.4M -$51.6M -140% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$36.9M -$18.4M -99.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$18.5M -$2.41M -15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$16.1M -$1.99M -14.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$14.1M -$939K -7.16% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-17
2017 -$13.1M -$7.99M -156% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 -$5.13M +$40.1M +88.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$45.3M -$21.8M -92.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-03
2014 -$23.5M -$7.71M -49% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 -$15.7M -$6.1M -63.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 -$9.65M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.